This technology is a high-throughput method to introduce single or multiple genetic insertions in human cell lines.

This technology is a gene therapy based on engineered chaperone protein variants that rescue toxic protein aggregation for the treatment of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and related neurodegenerative diseases.

This technology is a method for downcycling waste from lithium-ion batteries to synthesize precursor materials for sodium-ion batteries.